Vir Biotechnology, Inc. - Common Stock (VIR)

Historical Holders from Q4 2019 to Q3 2025

Symbol: VIR on Nasdaq
Type / Class: Equity / Common Stock
Shares outstanding: 137,278,139
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 107,007,238
Holdings value: $610,804,629
% of all portfolios: 0.001%
Number of holders: 209
Number of buys: 87
Number of sells: -105
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Vir Biotechnology, Inc. - Common Stock (VIR)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BlackRock, Inc.	10.8%		$93,255,785		14,826,039		BlackRock, Inc.	31 Mar 2025

Institutional Holders of Vir Biotechnology, Inc. - Common Stock (VIR)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	107,007,238	$610,804,629	-$20,189,064	$720,352	$1,356,125	$5.71	209
2025 Q2	110,838,661	$558,775,027	+$84,580,503	$757,512	$1,721,664	$5.04	211
2025 Q1	93,307,654	$604,780,740	+$27,869,791	$1,691,988	$1,666,008	$6.48	230
2024 Q4	88,707,515	$651,126,620	+$14,506,884	$1,720,915	$9,401,072	$7.34	202
2024 Q3	87,600,991	$656,230,226	-$4,592,687	$8,915,347	$947,485	$7.49	195
2024 Q2	88,056,992	$783,680,407	-$9,558,987	$1,170,350	$2,056,790	$8.9	213
2024 Q1	88,814,549	$899,654,431	+$7,160,790	$1,847,712	$1,788,958	$10.13	205
2023 Q4	88,171,139	$887,025,787	+$1,493,653	$1,536,162	$1,808,788	$10.06	202
2023 Q3	88,255,499	$826,977,393	-$227,669,705	$499,421	$855,481	$9.37	212
2023 Q2	90,761,353	$2,226,351,489	+$60,012,170	$19,758,915	$10,170,138	$24.53	222
2023 Q1	88,385,448	$2,056,730,043	+$54,021,550	$4,539,977	$6,822,764	$23.27	226
2022 Q4	86,118,572	$2,179,650,166	-$15,704,818	$1,867,878	$3,791,586	$25.31	219
2022 Q3	86,915,381	$1,675,900,472	-$11,606,508	$3,217,000	$3,344,000	$19.28	208
2022 Q2	86,086,454	$2,193,070,491	+$146,002,800	$4,526,000	$5,547,000	$25.47	201
2022 Q1	81,103,450	$2,086,374,530	-$14,155,763	$9,034,000	$13,586,000	$25.72	191
2021 Q4	78,095,522	$3,252,220,942	+$158,691,641	$34,880,000	$29,066,800	$41.87	203
2021 Q3	74,464,481	$3,240,626,324	-$19,547,865	$12,826,000	$21,398,000	$43.52	169
2021 Q2	74,156,851	$3,506,017,317	+$66,755,814	$11,422,000	$26,500,000	$47.28	156
2021 Q1	75,409,279	$3,865,770,922	-$99,056,866	$29,427,000	$28,792,000	$51.27	151
2020 Q4	76,141,156	$2,039,280,477	+$150,971,873	$12,794,000	$10,247,100	$26.78	136
2020 Q3	70,048,123	$2,405,706,821	+$553,884,772	$4,686,000	$4,785,000	$34.33	117
2020 Q2	53,528,634	$2,192,860,452	+$657,421,714	$9,431,000	$8,330,000	$40.97	109
2020 Q1	37,861,951	$1,297,525,769	-$4,041,452	$329,000	$370,000	$34.27	61
2019 Q4	36,584,366	$460,028,000	+$460,028,135			$12.57	38